REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,066 | -54.7% | 93 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,353 | -21.4% | 93 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $2,995 | +116.6% | 93 | +22.4% | 0.00% | +100.0% |
| Q4 2022 | $1,383 | -30.8% | 76 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $2,000 | +100.0% | 76 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $1,000 | 0.0% | 76 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,000 | -50.0% | 76 | -17.4% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | -33.3% | 92 | -7.1% | 0.00% | -50.0% |
| Q3 2021 | $3,000 | 0.0% | 99 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | 0.0% | 99 | -8.3% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | 0.0% | 108 | -12.2% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | +50.0% | 123 | +83.6% | 0.00% | +100.0% |
| Q3 2020 | $2,000 | 0.0% | 67 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $2,000 | +100.0% | 67 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $1,000 | 0.0% | 67 | +103.0% | 0.00% | 0.0% |
| Q4 2019 | $1,000 | – | 33 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |